Curated News
By: NewsRamp Editorial Staff
April 03, 2026
Ezalife's Button Huggie® Cuts Feeding Tube Dislodgement by 77%
TLDR
- Ezalife's Button Huggie device offers a 77% reduction in feeding tube dislodgement, positioning the company as a disruptive force in the $1.9 billion market with strong clinical validation.
- Ezalife's FDA-registered Button Huggie device stabilizes G-buttons using a purpose-built design, achieving a 77% reduction in dislodgement and a 270% increase in parent satisfaction.
- Ezalife's device reduces patient discomfort and emergency interventions, improving daily life for families and caregivers while addressing a long-standing challenge in patient care.
- Ezalife's patented Button Huggie replaces decades-old tape and gauze methods with an innovative device that has achieved a remarkable 77% reduction in feeding tube dislodgement.
Impact - Why it Matters
This news matters because feeding tube dislodgement is a common, serious complication affecting hundreds of thousands of patients globally, particularly children, the elderly, and those with chronic conditions. Each dislodgement can lead to infection, hospitalization, surgical re-insertion, nutritional deficits, and significant distress for patients and caregivers. By providing a clinically validated, patent-protected solution that dramatically reduces this risk while vastly improving user satisfaction, Ezalife addresses a critical gap in standard care. Successful adoption could reduce healthcare costs associated with emergency interventions, minimize patient trauma, and improve quality of life for vulnerable populations, representing a meaningful step forward in medical device innovation for essential daily care.
Summary
Ezalife, a medical device company based in Columbus, Ohio, has announced groundbreaking clinical results for its innovative Button Huggie® device, achieving a remarkable 77% reduction in feeding tube dislodgement. This addresses a critical, long-standing challenge in patient care where traditional methods using tape and gauze have remained largely unchanged for decades, often leading to patient discomfort, complications, and emergency interventions. The FDA-registered device is specifically designed to stabilize G-buttons more effectively, representing a significant advancement in a segment of the $1.9 billion feeding tube market.
Beyond the compelling clinical data, Ezalife reported exceptionally strong patient and caregiver satisfaction metrics, including an approximately 270% increase in parent satisfaction compared to traditional methods and a Net Promoter Score of 76, which significantly outpaces the industry average of 46. The company emphasized that these results highlight both the clinical effectiveness and the profound real-world impact on families, stating, "We're not just improving outcomes; we're improving daily life." The Button Huggie® is protected by a robust intellectual property portfolio, including a granted U.S. patent with 18 claims and additional international patents across Europe, the UK, Canada, China, and Japan, solidifying Ezalife's position as a category innovator.
As Ezalife positions itself as a disruptive force in post-operative and long-term care, its ongoing StartEngine campaign, which you can learn more about via the StartEngine campaign, is approaching its close on April 6, attracting investor attention at the intersection of healthcare innovation and proven clinical validation. The company's mission is to replace outdated standards of care with precision-engineered, patient-centered solutions, and the full details of this news release are available on www.newmediawire.com. For further information, contact Chief Marketing Officer Kara Fagan at kfagan@ezalife.com.
Source Statement
This curated news summary relied on content disributed by NewMediaWire. Read the original source here, Ezalife's Button Huggie® Cuts Feeding Tube Dislodgement by 77%
